Dysregulated STAT3 activity, whether through hyperactivation or inactivation, has been implicated in various human diseases, including atherosclerosis, bone‐related disorders, neurological conditions, autoimmune diseases, and cancer. The gene discussed is STAT3; the disease is atherosclerosis.